Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zoetis Inc Cl A 10 Sylvan Way Parsippany NJ 07054 USA

www.zoetis.com Employees: 13,800 P: 973-822-7000

Sector:

Medical

Description:

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.

Key Statistics

Overview:

Market Capitalization, $K 54,932,380
Enterprise Value, $K 59,515,380
Shares Outstanding, K 440,693
Float, K 439,900
% Float 99.82%
Short Interest, K 10,884
Short Float 2.47%
Days to Cover 2.02
Short Volume Ratio 0.55
% of Insider Shareholders 0.18%
% of Institutional Shareholders 92.80%

Financials:

Annual Sales, $ 9,256 M
Annual Net Income, $ 2,486 M
Last Quarter Sales, $ 2,400 M
Last Quarter Net Income, $ 721,000 K
EBIT, $ 3,462 M
EBITDA, $ 3,959 M

Growth:

1-Year Return -26.40%
3-Year Return -23.91%
5-Year Return -23.68%
5-Year Revenue Growth 47.86%
5-Year Earnings Growth 62.64%
5-Year Dividend Growth 162.12%

Per-Share Information:

Most Recent Earnings 1.70 on 11/04/25
Next Earnings Date 02/12/26 [BMO]
Earnings Per Share ttm 6.34
EPS Growth vs. Prev Qtr -3.41%
EPS Growth vs. Prev Year 7.59%
Annual Dividend & Yield (Paid) 2.00 (1.60%)
Annual Dividend & Yield (Fwd) 2.00 (1.60%)
Most Recent Dividend 0.530 on 01/20/26
Next Ex-Dividends Date 01/20/26
Dividend Payable Date 03/03/26
Dividend Payout Ratio 30.43%

ZTS Ratios

Ratio
Price/Earnings ttm 19.76
Price/Earnings forward 18.50
Price/Earnings to Growth 2.55
Return-on-Equity % 57.19%
Return-on-Assets % 19.53%
Profit Margin % 26.86%
Debt/Equity 1.31
Price/Sales 5.93
Price/Cash Flow 17.72
Price/Book 10.29
Book Value/Share 12.18
Interest Coverage 14.92
60-Month Beta 0.97

ZTS Dividends

Date Value
01/20/26 $0.5300
10/31/25 $0.5000
07/18/25 $0.5000
04/21/25 $0.5000
01/21/25 $0.5000
10/31/24 $0.4320
07/18/24 $0.4320
04/18/24 $0.4320
01/18/24 $0.4320
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar